Published: 24 February 2020
The school teams are now visiting secondary schools across the country to offer the second dose of HPV vaccine and a dose of MenACWY to all first-year students.
The Director of the National Immunisation Office (NIO) Dr Lucy Jessop said “On behalf of the HSE National Immunisation Office we would like to thank the school teams for their hard work in giving the vaccines through the school programme and answering questions from parents, students and schools."
The NIO is very encouraged by the uptake for the 1st dose of HPV vaccine for first-year students since September 2019. This is the first year that boys have also been offered the HPV vaccine and school teams are reporting very busy clinics across the country. The NIO hope to report on the uptake for the boys and girls programme later this year. The uptake for the HPV vaccine in Co. Clare is almost 90%. "This is testament to the selfless advocacy of the late Laura Brennan and the continuing work of the Brennan family to promote the importance of the HPV vaccine.
We are asking HSE staff to continue sharing the facts about the importance of getting HPV vaccine through the HSE school vaccination programme. We have also developed an e-learning module to support the HPV vaccination programme visit www.hseland.ie to complete the module today it will only take 30 minutes" concluded Dr Jessop.
The NIO is delighted to now be offering the MenACWY vaccine to all first-year students in secondary school through the HSE school vaccination programme. Over the last couple of years, there has been an increase in meningococcal disease in this age group so it is important that first-year students get the MenACWY vaccine now to protect them.”
Facts about HPV
- The HPV virus causes 1 in 20 cancers worldwide
- Each year in Ireland about 400 people will be diagnosed with a cancer caused by the HPV virus
- The HPV vaccine now protects against the types of HPV that cause 9 out of 10 cervical cancers. The vaccine also protects against most cases of vulval, anal and vaginal cancers and most cases of genital warts
- Over 84 countries have a HPV vaccine programme, with more than 20 of these countries giving the vaccine to boys and girls including Ireland, UK, Australia, New Zealand and Italy
- The HPV vaccine has greatly reduced cases of pre-cancers of the cervix in young women in many countries including Australia, Sweden, the US and the UK
- In countries where the HPV vaccine is used, the number of cases of genital warts has decreased dramatically in both young women and men
- Even if females have had the HPV vaccine, they should have their cervical screening test (smear test) each time it's due. This is because the HPV vaccine doesn't give complete protection against cervical cancer.
We welcome your support in sharing the facts, about the importance of getting HPV vaccine, by posting content, tweeting or retweeting and engaging on your social media platforms.